Alexion Pharmaceuticals, Inc. · 3 days ago
Tumor Lead, Lung Cancer - Oncology Outcomes Research
Gaithersburg, Maryland, United States of America
Full-time
Hybrid
Director/Executive
$249K/yr - $374K/yr
15+ years expAlexion Pharmaceuticals, Inc. is seeking a Tumor Lead for Lung Cancer within their Oncology Outcomes Research team. This role involves developing and implementing health outcomes and real-world studies, while leading a team and strategically communicating with internal and external partners.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Lead the development and execution of the Global and US tumor evidence strategy including real world evidence, and other activities to assess, quantify and communicate the value proposition for AZ’s oncology portfolio
Within the Medical Governance process, lead the Tumor Evidence Review Team (ERT) to ensure the scientific rigor of AZ sponsored research, overseeing approval of all study concepts, protocols and publications
Oversee a team with responsibility to support the Global and US market. The team will deliver both the strategy and technical execution of projects for that specific tumor
Responsible for strategically communicating and influencing a diverse group of internal and external partners at the senior level in Medical Affairs, Commercial and R&D
Proactive relationship and communications with key stakeholders who are their counterparts in Global Medical Affairs, US Medical Affairs, Regional Medical Affairs (EUCAN and International), Global and US Market Access and Pricing teams and other relevant cross-functional teams
Experienced manager who can coach and mentor researchers with diverse technical skills and enable them to deliver impactful and measurable results
Coaches and mentors individuals at all career levels to help them grow in both soft and hard skills
Oversee the development and execution of research plans for tumors and molecules
Identifies efficiencies in research methodology and execution of projects including but not limited to real world research, claims database analyses, registries, comparative effectiveness research, patient preference analyses, modeling and literature reviews
Qualification
Required
15 + years experience in the pharmaceutical industry
graduate degree (MS, MPH, PhD) in health economics (HE), epidemiology, outcomes research (OR) and/or related fields
In-depth expertise with research methods for real world research, HEOR projects including pharmacoepidemiologic models
Scientific expertise in oncology with knowledge of different data sources
Proven ability with a track record of success in developing and leading teams
Strong written and verbal communication skills as well as strong leadership and interpersonal skills
Demonstrated expertise in analytical, judgment and problem-solving skills
Travel-25%
Benefits
Various incentives—an opportunity to receive short-term incentive bonuses
Equity-based awards for salaried roles
Commissions for sales roles
Qualified retirement programs
Paid time off (i.e., vacation, holiday, and leaves)
Health, dental, and vision coverage in accordance with the terms of the applicable plans
Company
Alexion Pharmaceuticals, Inc.
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
1001-5000 employees
H1B Sponsorship
Alexion Pharmaceuticals, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (49)
2024 (57)
2023 (51)
2022 (29)
2021 (27)
2020 (17)
Funding
Current Stage
Public CompanyTotal Funding
$5.8M2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO
Leadership Team
Frederic Chereau
SVP, Strategy and Business Development
Imran Shakur
Director, IRT and Technology Lead
Recent News
BioWorld Financial Watch
2026-01-17
bloomberglaw.com
2025-12-20
Company data provided by crunchbase